Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Phathom Pharmaceuticals, Inc. | StockGist | StockGist

Companies
PHAT
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings PHATSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Phathom Pharmaceuticals, Inc.

Filed Aug 28, 2025

Accepted Aug 27, 2025, 8:00 PM ET

CIK 0001783183

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

5.00%

Shares Owned

70,943,708

Reporting Person

Phathom Pharmaceuticals, Inc.

Person Type

CO

CUSIP: 71722W107

Amendment History

3 filings

SCHEDULE 13G
Original
Aug 13, 20250001104659-25-077523
SCHEDULE 13G/A
Amendment 1
Aug 25, 20250001104659-25-082527
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Aug 28, 20250001641172-25-025812

Key Facts

% of Class

5.00%

Shares Owned

70,943,708

Recent Filings

Phathom Pharmaceuticals, Inc.3 weeks ago

Phathom Pharmaceuticals, Inc.1 months ago

Phathom Pharmaceuticals, Inc.1 months ago

Phathom Pharmaceuticals, Inc.2 months ago

Phathom Pharmaceuticals, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice